Pfizer – On what basis did they claim 95% ?

On What Basis Did Pfizer Claim 95%?

“Buried within the FDA’s briefing document for the Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting on Dec. 10, 2020, for the Pfizer-BioNTech COVID-19 Vaccine-there is alarming data and a concerning issue which should be addressed.

Firstly, it’s worth pointing out that Pfizer used a ‘central laboratory’ (see pg 13) of its choice, to confirm COVID-19 cases using a PCR test ‘If, at any time, a participant develops acute respiratory illness, an illness visit occurs. Assessments for illness visits include a nasal swab, which is tested at a central laboratory using a reverse transcription-polymerase chain reaction (RT-PCR) test’

I’ve previously written an in-depth investigative report on the PCR test. The cycle threshold (CT) value used, greatly impacts the outcome of a test.

According to a study by Jaafar et al., the authors found that when running PCR tests with 35 cycles or more – the accuracy dropped to 3% …” 🔗Read more